Ensoma Launches With Takeda Partnership On Myeloablation-Free Gene Therapy

 
• By Alaric DeArment
  
Takeda Tokyo HQ
Takeda is betting $100m - and potentially more than $1bn - on startup Ensoma. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip